Diabetes Information [Return To Home Page]

Pancreas Transplants - A Solution For Type 1 Diabetes Sufferers?


Type 1 diabetes was formerly known as juvenile diabetes or insulin dependent diabetes mellitus. Type 1 diabetes matures quickly and symptoms are very visible.

This type of diabetes occurs when the body's immune system destroys pancreatic cells. These cells are the insulin producing cells. This type of diabetes affects mostly children and young adults. Risk factors for type1 diabetes include autoimmune, genetics, and environmental factors.

Many clinical studies have shown that an option for type 1 diabetes treatment is the pancreas transplantation. For some patients, surgeons can restore the function of the pancreas with an islet cell transplant.

The most important benefit of pancreas transplantation is freedom from dependence on insulin. Although this is significant, this is not recommended treatment for diabetes unless there is a need for a kidney transplant as well.

On the other hand, pancreas transplants still remains problematic in that the immune system still can attack new pancreas cells. Some people who have transplants do find that the transplanted pancreas is attacked and the insulin-producing cells are killed off after operation.

At this time, pancreas transplants do not always provide permanent cures, and people who have transplants must take anti-rejection medication and immune-system suppressing drugs.

Many research teams are still working on this immune system problem that seems to be the root cause of type 1 diabetes (sometimes called auto-immune diabetes).

This is main reason that pancreas transplants are still only being studied experimentally and are not considered currently to be an automatic cure for all patients with type 1 diabetes.

Valerian, freelance writer specialized in health issues affecting men
http://www.mens-health-events.info/diabetes.php


MORE RESOURCES:

dBTechno

Amylin shares up on FDA response for diabetes drug
The Associated Press
... of Amylin Pharmaceuticals jumped 13 percent Monday as the Food and Drug Administration asked for more information on its potential diabetes treatment. ...
FDA Rejects Amylin Diabetes Drug, Seeks More InfoWall Street Journal
FDA denies approval of Amylin, Lilly diabetes drugReuters
Diabetes Drug From Lilly, Amylin Under ScrutinyForbes
Cincinnati.com -Xconomy -dBTechno
all 240 news articles »


FDA Grinds MannKind On Diabetes Drug
Forbes
... letter from the Food and Drug Administration regarding its New Drug Application for Afrezza, an inhalable insulin medicine intended to treat diabetes. ...
FDA Delays Mannkind Diabetes Approval: BioBuzzTheStreet.com (subscription)
FDA Requests Additional Information Regarding AFREZZA(TM) in Complete Response ...MarketWatch (press release)
FDA requires more details on MannKind's AfrezzaReuters
BusinessWeek -Morningstar.com -RTT News
all 31 news articles »



dBTechno

Novartis Drugs Don't Prevent Type 2 Diabetes?
CNM News Network
Novartis Drugs Don't Prevent Type 2 Diabetes? A recent study shows that two drugs by Novartis AG fail to prevent type 2 diabetes. ...
Novartis drugs fail to prevent diabetes in the overweightXinhua
Search for Better Diabetes Therapy Falls ShortWall Street Journal
Drugs in pre-diabetics do little to slow progression to diabetes or to heart ...Los Angeles Times (blog)
dBTechno -EurekAlert (press release) -Ennahar
all 63 news articles »


E! Online (blog)

'The Celebrity Apprentice': $100 burgers for diabetes
Zap2it.com (blog)
Some donors leave tips of well over $1000, in support of Bret Michaels' donation to children with Type 1 Diabetes. In a bit of a twist, Donald Trump asks ...
Bret Michaels of Poison: 'Every time I'm in Pennsylvania, I have a great time'PennLive.com (blog)
The Celebrity Apprentice Episode 9-01 ReviewInside Pulse (blog)
Celebrity Apprentice Cast 2010:The Celebrity Apprentice Season 3 TV ShowSpreadit

all 218 news articles »



TopNews United States

Tricor Not Useful for Diabetics
TopNews United States
The trial helped in identifying ways to reduce the risk of heart attacks and strokes in people with type-2 diabetes. According to the NHLBI, ...
No heart benefit seen with fibrates in diabeticsReuters
Abbott's TriCor Shows No Benefit For Diabetics In StudyWall Street Journal
Abbott's TriCor With Statin Fails to Cut Diabetic Heart RiskBusinessWeek
Forbes (blog) -MedPage Today -PR Newswire (press release)
all 82 news articles »


NGM lands $51M for preclinical diabetes work
FierceBiotech
The company notes that people who undergo gastric bypass often experience immediate remission of diabetes, even before they've lost significant weight. ...
NGM closes 1st tranche of $51M roundBizjournals.com
NGM Biopharmaceuticals Raises $51 Million in Series B Financing and Appoints ...PR Newswire (press release)

all 7 news articles »


BBC News

Viewpoint: Type 2 diabetes and exercise
Endocrine Today
How does exercise affect blood glucose level in a patient with type 2 diabetes and why is it important? Exercise can be very useful in optimizing blood ...
No quick drug fix for high diabetes riskBBC News
Key type 2 diabetes treatments do not halt disease in early stagesDiabetes.co.uk
Eating Fruit at Work Keeps Our Diet on TrackDiet.co.uk
Fruitful Office - Office Fruit News Site (blog)
all 11 news articles »


Xoma initiates Phase II diabetes trial
Trading Markets (press release)
Xoma, a developer of therapeutic antibodies, has initiated a Phase II clinical trial of XOMA 052, its antibody to interleukin-1 beta, in type 1 diabetes ...
XOMA 052 Prevents Adverse Cardiac Remodeling in Animal Model of Heart AttackCNNMoney.com (press release)
Type 2 Diabetes Drug XOMA 052 Takes Anti-Inflammatory ApproacheMaxHealth

all 17 news articles »

Google News






home | site map
© 2006